Discover our Portfolio

Deinobiotics was created in 2009 by Deinove (Truffle Capital portfolio) and with the support of OSEO, the Languedoc-Roussillon Region and the European Regional Development Fund (ERDF). Deinobiotics focuses on a research program to explore the possibilities offered by Deinococci in medical research, including their antibiotic and antifungal activity. Today, Deinobiotic’s R&D program primarily targets antibiotics capable of resisting to hospital germs responsible for nosocomial infections (Gram-negative bacteria and fungi).



Truffle Capital

Contact Truffle Capital

1 + 5 =

[sg_popup id=2]
5 Rue de la Baume, 75008 Paris, France Tel: +33 1 82 28 46 00



Truffle Capital

5 Rue de la Baume 75008 Paris France
Tel: +33 1 82 28 46 00

© 2018 Truffle Capital

Truffle Capital 2018

Social Networks